Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-970-9 | CAS number: 549-56-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comprehension of 5 case reports.
Data source
Reference
- Reference Type:
- publication
- Title:
- Quinine Sensitivity
- Author:
- Calnan, C. D. and Caron, G. A.
- Year:
- 1 961
- Bibliographic source:
- Br Med J. 2(5269): 1750–1752
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- case report
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Not intended cases of contact dermatitis, proven by a patch test to result from quinine.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Automatically generated during migration to IUCLID 6, no data available
- IUPAC Name:
- Automatically generated during migration to IUCLID 6, no data available
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): sensitization is caused by various quinine-containing products like e.g. contraceptive pessaries, hair-restoring lotion etc. To examine sensitization a Patch test was done using quinine sulphate.
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- not specified
- Subjects:
- - Number of subjects exposed:1- Sex: male- Age: 40- Number of subjects exposed:1- Sex: male- Age: 25- Number of subjects exposed:1- Sex: male- Age: 31- Number of subjects exposed:1- Sex: male- Age: 36- Number of subjects exposed:1- Sex: male- Age: 40
- Clinical history:
- Case 1:- Symptoms, onset and progress of the disease: rash of 10 weeks' duration on his arms, legs, and genitalia which was diagnosed clinically as lichen planus.- History of allergy: The patient gave a previous history of a contact dermatitis of the penis after his wife's use of a contraceptive pessary containing quinine. Some time later he suffered an episode of an eruption on the genitalia, palms, and soles after the ingestion of quinine.- Aggravating factors both in home and workplace: the patient's wife had used a quinine containing contraceptive pessary.Case 2:- Symptoms, onset and progress of the disease: eczematous eruption of his perineum and genitalia which had been present for two months.- Aggravating factors both in home and workplace: It started after his wife had begun using a proprietary brand of a quinine containing contraceptive pessary.Case 3:- Symptoms, onset and progress of the disease: balanitis- Aggravating factors both in home and workplace: The patient had been using a rubber condom and his wife may have been using chemical contraceptive pessaries.Case 4:- Symptoms, onset and progress of the disease: acute dermatitis of the scalp, face, neck, and left hand of two weeks' duration.- History of allergy: The patient had used a proprietary brand of quinine containing hair-restoring lotion. At the age of 22 he had had an eruption on the genitalia after his wife's use of a chemical contraceptive containing quinine. In 1958 he again developed an acute dermatitis of the face and hands. This had begun on the day after he had had a tooth extracted, and, although none of the materials used by his dentist contained quinine, it is possible that the patient had taken a quinine-containing analgesic tablet.Case 5:- Symptoms, onset and progress of the disease: generalized itching, macular, erythematous eruption- History of allergy: In childhood the patient had developed a scarlet-fever-like rash after taking a tonic", he was subsequently told that he was sensitive to quinine. When aged 34 he had an acute dermatitis of the scalp after using a proprietary hair lotion (presumed to have contained quinine)
- Route of administration:
- dermal
- Details on study design:
- Case 1-4:TYPE OF TEST(S) USED: patch test (epicutaneous test)ADMINISTRATION- Vehicle / solvent: water- Test material: 2 % solution of quinine sulphate- Controls: only in Case 2 - 0.1 % mercuric chlorid and ammoniated mercury Case 5:TYPE OF TEST(S) USED: patch test as well as scratch and intradermal testADMINISTRATION- Test material: 1 % solution of quinine sulphate
Results and discussion
- Results of examinations:
- Case 1:SYMPTOMS- duration of symptoms observed: 10 weeks' durationNO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION- Number of subjects with positive reactions:1RESULT OF CASE REPORT:The patient gave a previous history of a contact dermatitis of the penis after his wife's use of a contraceptive pessary containing quinine. Some time later he suffered an episode of an eruption on the genitalia, palms, and soles after the ingestion of quinine. His general practitioner suspected that the presenting rash was also due to quinine sensitivity, since it seemed to have begun after the patient's wife had again used a quinine containing contraceptive pessary. A patch test to a 2% solution of quinine sulphate was positive after 48 hours.Case 2:SYMPTOMS- duration of symptoms observed: 2 month durationNO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION- Number of subjects with positive reactions:1RESULT OF CASE REPORT:A 25-year-old man with an eczematous eruption of his perineum and genitalia which had been present for two months; it started after his wifehad begun using a proprietary brand of a quinine containing contraceptive pessary. Patch tests to the pessary and to a 2% solution of quinine sulphate were positive. Tests with 0.1 % mercuric chloride and ammoniated mercury ointment were negative.Case 3:NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION- Number of subjects with positive reactions:1RESULT OF CASE REPORT:A man aged 31 was referred in 1957 by his general practitioner as a case of balanitis, possibly due to contact dermatitis. He had been using a rubber condom. Positive patch tests were obtained with a piece of rubber from the condom, a quinine-containing pessary, and a 2% solution of quinine sulphate.Case 4:SYMPTOMS- duration of symptoms observed: 2 week´s durationNO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION- Number of subjects with positive reactions:1RESULT OF CASE REPORT:A man aged 36 was first seen in May, 1953, with an acute dermatitis of the scalp, face, neck, and left hand of two weeks' duration. This had started on his bald scalp the day after he had used a proprietary brand of quinine containing hair-restoring lotion. On this occasion a patch test with 2% quinin sulphate was positive. Case 5:NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION- Number of subjects with positive reactions:1RESULT OF CASE REPORT:A man aged 40 was seen in March, 1961, with a generalized itching, macular, erythematous eruption. He had recently had an entirely similar episode. His previous history was that in childhood he had developed a scarlet-fever-like rash after taking a tonic", he was subsequently told that he was sensitive to quinine. When aged 34 he had an acute dermatitis of the scalp after using a proprietary hair lotion (presumed to have contained quinine). Skin tests were done with I % quinine sulphate in normal saline. The scratch and intradermal tests gave negative immediate-type reactions, but the patch test was strongly positive after 72 hours.
Applicant's summary and conclusion
- Conclusions:
- Quinine sulphate is a potent contact sensitizer. In the case report all tested patients were sensitized.
- Executive summary:
Five patients expected to be sensitive to quinine sulphate were tested with a standard patch test. All five patients reacted to a 2% (4 patients) or 1% (1 patient) solution of quinine sulphate. The patients became sensitized after exposure. Therefore Quinine bisulphate is expected to be a contact allergen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.